Dr. Davies has experience in conducting patent prosecution in the pharmaceutical field, primarily on small molecule therapeutics. She works with clients from startup to commercial-stage pharmaceutical companies to ensure strategic protection of intellectual property assets under strict timeline requirements.
Dr. Davies assists clients with drafting patent applications and responding to United States Patent Office substantive actions; performs freedom-to-operate and patentability analyses for client assets; and collaborates with foreign associates to advance the prosecution of client applications in foreign jurisdictions.
Dr. Davies has extensive synthetic organic chemistry experience through both her PhD studies and her postdoctoral research at California Institute of Technology, focusing on the synthesis of complex natural products and the discovery of new reaction methodologies.
Prior to joining Goodwin, Dr. Davies spent 13 years as a medicinal chemist at a mid-size Boston pharmaceutical company. She has led drug discovery efforts on two early stage antiviral projects and has worked as a drug discovery scientist on projects in diverse therapeutic areas such as oncology, antibacterials and CNS.
Dr. Davies is an author on seven peer-reviewed scientific papers and 13 granted U.S. patents.